Venture-Backed Startups
132,648 companies with verified investor relationships.
0 investors
ESP is a logistics technology company. The page presents its leadership and team but does not describe its specific products or customers.
1 investor
ESP Water provides infrastructure consulting and adoption support for water utilities, helping clients plan and implement network solutions across water, electricity, gas, EV charging, and district heating systems.
1 investor
0 investors
Espada Energy is an oil and gas company focused on acquiring and developing upstream assets across multiple basins in the United States. It is led by a team with experience in the North American upstream energy sector.
1 investor
eSpark offers an educational platform for iPad and the web that assembles learning materials into individualized study paths for students. Teachers use the system to assign differentiated instruction matched to each learner's level and academic goals. The product is aimed at K-12 classrooms in the United States.
1 investor
ESPA is a skincare and spa company that formulates high-performance skincare products using natural ingredients and advanced biotechnology, while also operating spa treatments and partnering with luxury hospitality properties worldwide. The company emphasizes holistic wellness combining skincare, spa therapies, and sensory experiences for mental and physical wellbeing.
1 investor
0 investors
Esper provides device management software using DevOps principles for company-managed devices, automating provisioning and exception-based management across Android and other platforms. It serves enterprises and device manufacturers seeking operational efficiency beyond traditional mobile device management.
6 investors
Esper builds a regulatory platform that helps government agencies research, draft, and manage regulations and policies through structured workflows and publication portals. The company serves federal, state, and local government agencies seeking to simplify rulemaking and policy administration.
6 investors
Esper provides hyperspectral satellite imagery and geochemical analysis to identify critical minerals and alteration zones for mining exploration and environmental monitoring. The company serves mining and exploration firms targeting lithium, gold, copper, and rare earth elements globally.
3 investors
0 investors
Esperance develops targeted oncology therapeutics designed to selectively kill cancer cells, including chemotherapy-resistant cells, via a proprietary Cationic Lytic Peptide (CLYP) platform, membrane-disrupting peptides, and antibody drug conjugates. The company operates from Houston, Texas near the Texas Medical Center, with MD Anderson Cancer Center as a strategic partner.
1 investor
Esperanto Technologies developed the ET-SoC-1, a RISC-V based inference chip with over a thousand low-power cores, along with AI/HPC compute servers for generative AI inference, high-performance computing, and mixed AI+HPC workloads. The company has ceased operations and its IP was acquired by Nekko.ai.
2 investors
0 investors
0 investors
Esperovax develops oral mRNA vaccines delivered as pills or gummies that synthesize the mRNA in the intestines, where 70% of the immune system resides. The company aims to address production and logistical challenges of traditional mRNA vaccines while improving patient acceptance.
2 investors
Esperta Health provides an in-home and virtual wound management program that combines clinical expertise with technology to standardize care and improve healing outcomes. The platform serves patients requiring wound care management across various settings.
1 investor
Esperto Medical is a medical device company developing compact, sensor-based diagnostic and monitoring technology, drawing on expertise in electrical engineering, imaging, and machine learning. Its work targets continuous physiological monitoring, including blood pressure sensing, for healthcare applications.
2 investors
Espervita Therapeutics develops metabolic reprogramming therapies targeting liver and kidney disease, with a lead program in acetyl-CoA metabolic enzyme inhibitors. The company focuses on treating progressive metabolic liver diseases and related conditions.
3 investors
Esphera designs transgenes that enable budding exosomes to carry multimeric proteins for therapeutic applications, with initial focus on modifying tumor-derived exosomes to create immunostimulatory cancer vaccines.
2 investors
0 investors
0 investors
Espl, headquartered in Singapore, organizes competitive video game tournaments and operates an associated media network. Its events run both online and at physical venues, bringing together players, teams, and industry participants across multiple regions. The company's audience consists of gamers competing in or following esports competitions.
1 investor